Greece to beat healthcare cost-cutting goals

Debt-laden Greece will exceed its target of slashing healthcare spending by €1.2 billion ($1.4 billion) in 2010 thanks to a new drug-pricing regime from September, the country's economy minister says. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.